SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-20-000118
Filing Date
2020-11-09
Accepted
2020-11-09 16:06:50
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20200930.htm   iXBRL 10-Q 1194395
2 EX-10.1 sesn-ex101qilulicensea.htm EX-10.1 523018
3 EX-31.1 sesn-09302020x10qex311.htm EX-31.1 11775
4 EX-31.2 sesn-09302020x10qex312.htm EX-31.2 11700
5 EX-32.1 sesn-09302020x10qex321.htm EX-32.1 6265
6 EX-32.2 sesn-09302020x10qex322.htm EX-32.2 6229
  Complete submission text file 0001485003-20-000118.txt   6207778

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20200930.xsd EX-101.SCH 46419
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20200930_cal.xml EX-101.CAL 51822
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20200930_def.xml EX-101.DEF 215628
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20200930_lab.xml EX-101.LAB 546948
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20200930_pre.xml EX-101.PRE 346649
12 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20200930_htm.xml XML 801226
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 201297713
SIC: 2834 Pharmaceutical Preparations